Dynamk Capital
Venture Capital Est. 2016
USD 24M
Estimated FUM
- Type
- Venture Capital
- HQ
- New York, NY, United States
- Founded
- 2016
- Focus
- Healthtech / Life Sciences
About
Dynamk Capital is an early stage Life Sciences investor and partner that looks to accelerate the growth and adoption of disruptive solutions and services. We are committed to advancing novel technologies for human health. We are passionate about creating the future of biotech and life sciences. We believe innovative services, tools and technologies are critical to enabling the discovery, development and production of life-saving therapies, delivering lower costs, and increasing access to medicines globally.
Life science entrepreneurs with highly disruptive, market-defining ideas have long struggled to secure the right mix of capital and expertise. Dynamk addresses this gap with deep domain and technical expertise, coupled with the strategic and commercialization experience to help these companies realize full potential.
Strategies
Venture Capital
Breadth not publicly established
Stated investment focus
Sources & freshness
Public evidence and reporting dates used for the structured profile. Internal confidence scores are not displayed.
Life Sciences · Venture Capital
Official firm description · Observed Aug 8, 2026
Healthcare & Life Sciences · Venture Capital
Official firm description · Observed Aug 8, 2026
Investment Focus
Investment size
USD 200K - USD 2M
Reported investment size. Actual commitments may vary by stage, ownership and follow-on participation.
Focus Areas
Stages
Seed Series A Series B
Focus
Healthtech / Life Sciences
Investment Geographies
Primary Markets
United States
Coverage
Country-focused Regions
North America
Coverage is a guide only.
Location
Office Presence
1 country
United States
1 known office
New York, NY, United States (HQ)
People also viewed
Northzone
Northzone is a European early-stage venture capital fund that invests in innovative consumer and enterprise companies in Europe and the US East Coast,. We invest primarily at the Series A and B stage, but selectively pursue seed investments. We have deep, long-standing technology expertise and benefit from the fact that the majority of our investment team have previously founded companies.
EQT Ventures
EQT Ventures is the venture capital arm of EQT, investing in high-growth technology companies across Europe and the US.
Versant Ventures
Versant Ventures is a venture capital fund focused on biotechnology and life sciences, with a primary focus on novel therapeutics targeting important unmet medical needs. Versant Ventures both develops its own projects, and invests in external companies. In both instances we provide the necessary funds to bring the product to launch. We have a large team of scientists, known as our Discovery Engines, which develop and validate new biological discoveries and technologies. We also invest in externally developed IP in companies throughout the United States, Canada and Europe.
Andreessen Horowitz
Andreessen Horowitz is an investment manager investing in technology companies from seed through growth stage across AI, bio and healthcare, consumer, crypto, enterprise, fintech, games, infrastructure and American dynamism.
Union Square Ventures
Union Square Ventures is a small collegial partnership based in New York that manages over $1B across seven technology-focused venture funds. Union Square Ventures is one of the most successful venture funds in the world and has been an early-stage investor in some of America's most successful startups such as Zynga, Indeed, Tumblr, Twitter, Lending Club, Etsy, Twilio and MongoDB. USV was founded in 2003 by Fred Wilson and Brad Burnham.
GV (Google Ventures)
GV is an independent venture capital firm launched as Google Ventures in 2009, with Alphabet as its sole limited partner. It invests from seed to growth in technology and life sciences and provides operating-partner support to founding teams.